NASDAQ:ADUS - Addus Homecare Stock Price, Forecast & News

Addus Homecare trades on the NASDAQ under the ticker symbol "ADUS."

Addus Homecare Co. (NASDAQ:ADUS) issued its quarterly earnings results on Monday, November, 4th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.49 by $0.13. The company earned $169.80 million during the quarter, compared to analysts' expectations of $160.25 million. Addus Homecare had a net margin of 3.35% and a return on equity of 8.00%. The company's quarterly revenue was up 23.3% on a year-over-year basis. View Addus Homecare's Earnings History.

Addus Homecare is scheduled to release their next quarterly earnings announcement on Monday, March 2nd 2020. View Earnings Estimates for Addus Homecare.

8 equities research analysts have issued 1-year price objectives for Addus Homecare's stock. Their forecasts range from $75.00 to $115.00. On average, they expect Addus Homecare's stock price to reach $96.29 in the next twelve months. This suggests a possible upside of 0.1% from the stock's current price. View Analyst Price Targets for Addus Homecare.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus Homecare in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Addus Homecare.

News articles about ADUS stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Addus Homecare earned a media sentiment score of 1.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Addus Homecare.

Addus Homecare saw a drop in short interest in December. As of December 13th, there was short interest totalling 618,600 shares, a drop of 12.5% from the November 28th total of 707,200 shares. Based on an average trading volume of 161,400 shares, the days-to-cover ratio is currently 3.8 days. Approximately 4.8% of the company's stock are short sold. View Addus Homecare's Current Options Chain.

Some companies that are related to Addus Homecare include Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), BioScrip (BIOS) and New York Health Care (BBAL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus Homecare investors own include AbbVie (ABBV), Align Technology (ALGN), Activision Blizzard (ATVI), Gilead Sciences (GILD), Energy Transfer LP Unit (ET), IBM (IBM), Pfizer (PFE), AT&T (T), Exxon Mobil (XOM) and Celgene (CELG).

Addus Homecare's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Calamos Advisors LLC (0.53%), Columbus Circle Investors (0.13%), Sheets Smith Wealth Management (0.08%), State of Alaska Department of Revenue (0.07%), Louisiana State Employees Retirement System (0.03%) and Eqis Capital Management Inc. (0.02%). Company insiders that own Addus Homecare stock include Brian Poff, Darby Anderson, David W Tucker, Eos Capital Partners Iii L P, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Susan T Weaver and W Bradley Bickham. View Institutional Ownership Trends for Addus Homecare.

ADUS stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, Eqis Capital Management Inc. and Louisiana State Employees Retirement System. Company insiders that have sold Addus Homecare company stock in the last year include Brian Poff, Darby Anderson, David W Tucker, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Susan T Weaver and W Bradley Bickham. View Insider Buying and Selling for Addus Homecare.

ADUS stock was acquired by a variety of institutional investors in the last quarter, including Columbus Circle Investors, Sheets Smith Wealth Management, Miles Capital Inc., Zurcher Kantonalbank Zurich Cantonalbank and State of Alaska Department of Revenue. View Insider Buying and Selling for Addus Homecare.

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ADUS stock can currently be purchased for approximately $96.22.

Addus Homecare has a market capitalization of $1.50 billion and generates $518.12 million in revenue each year. The company earns $17.50 million in net income (profit) each year or $1.69 on an earnings per share basis. Addus Homecare employs 33,153 workers across the globe.View Additional Information About Addus Homecare.

The official website for Addus Homecare is http://www.addus.com/.

Addus Homecare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]